Thursday, June 11, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1210 of 1,261
  1. US 6353151

    Transgenic model for heart failure

    The Regents of the University of Technology Office of Technology Transfer Β· Granted Mar 5, 2002 Β· Expires Feb 28, 2022

    expired
  2. US 6353097

    Nucleic acids encoding signal transduction inhibitors of allergic reactions

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Mar 5, 2002 Β· Expires Feb 28, 2022

    expired
  3. GB 2365868

    Polynucleotides and polypeptides of the G-protein coupled receptor AXOR87

    SMITHKLINE BEECHAM CORP [US] Β· Granted Feb 27, 2002 Β· Expires Feb 22, 2022

    expired
  4. US 6350589

    Compositions of highly-purified natural mixtures of type I interferon derived from leukocytes and methods

    Airgain, Inc. Β· Granted Feb 26, 2002 Β· Expires Feb 21, 2022

    expired
  5. US 6350479

    Treating depression with alcohol extracts of tobacco

    Regent Court Technologies, LLC Β· Granted Feb 26, 2002 Β· Expires Feb 21, 2022

    expired
  6. US 6350593

    Receptors for fibroblast growth factors

    The Regents of the University of California Β· Granted Feb 26, 2002 Β· Expires Feb 21, 2022

    expired
  7. US 6350729

    Inhibition of nitric oxide-mediated hypotension and septic shock with iron-containing hemoprotein

    The Board of Regents of the University of Texas System Β· Granted Feb 26, 2002 Β· Expires Feb 21, 2022

    expired
  8. US 6350785

    Methods and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors

    Maxim Pharmaceuticals, Inc. Β· Granted Feb 26, 2002 Β· Expires Feb 21, 2022

    expired
  9. US 6350741

    Inhibitors of interleukin-1&bgr; converting enzyme

    Vertex Pharmaceuticals Incorporated Β· Granted Feb 26, 2002 Β· Expires Feb 21, 2022

    expired
  10. US 6350769

    Gaba alpha receptors mediate inhibition of T cell responses

    The Regents of the University of California Β· Granted Feb 26, 2002 Β· Expires Feb 21, 2022

    expired
  11. US 6348466

    CRF receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. Β· Granted Feb 19, 2002 Β· Expires Feb 14, 2022

    expired
  12. US 6348571

    Corticotropin release inhibiting factor and methods of using same

    Northwestern University Β· Granted Feb 19, 2002 Β· Expires Feb 14, 2022

    expired
  13. US 6348481

    Pharmaceutical composition for angiotensin II-mediated diseases

    Takeda Chemical Industries Ltd. Β· Granted Feb 19, 2002 Β· Expires Feb 14, 2022

    expired
  14. US 6348493

    Treatment and prevention of hepatic disorders

    The Regents of the University of California Β· Granted Feb 19, 2002 Β· Expires Feb 14, 2022

    expired
  15. US 6348485

    Method for treating or preventing sleep disorders

    Takeda Chemical Industries Ltd. Β· Granted Feb 19, 2002 Β· Expires Feb 14, 2022

    expired
  16. US 6347633

    Treatment of hepatitis C using hyperthermia

    First Circle Medical, Inc. Β· Granted Feb 19, 2002 Β· Expires Feb 14, 2022

    expired
  17. US 6348445

    Biologically active peptides with reduced toxicity in animals and a method for preparing same

    Magainin Pharmaceuticals Inc. Β· Granted Feb 19, 2002 Β· Expires Feb 14, 2022

    expired
  18. US 6346236

    Sunscreens from vegetable oil and plant phenols

    The United States of America, as represented by the Secretary of Agriculture Β· Granted Feb 12, 2002 Β· Expires Feb 7, 2022

    expired
  19. US 6346411

    DNA encoding—candida albicans integrin-like protein

    Regents of the University of Minnesota Β· Granted Feb 12, 2002 Β· Expires Feb 7, 2022

    expired
  20. US 6346607

    APAF-1 an activator of caspase-3

    The Board of Regents of the University of Texas System Β· Granted Feb 12, 2002 Β· Expires Feb 7, 2022

    expired
  21. US 6346521

    Optically active 2R, 4S benzothiepin isomer

    Takeda Chemical Industries Ltd. Β· Granted Feb 12, 2002 Β· Expires Feb 7, 2022

    expired
  22. US 6346604

    Method for controlling conformation of cyclopentapeptide

    Takeda Chemical Industries Ltd. Β· Granted Feb 12, 2002 Β· Expires Feb 7, 2022

    expired
  23. WO 0210256

    EIN- ODER MEHRFACHQUARTΓ„RE POLYSILOXANE

    GE BAYER SILICONES GMBH & CO [DE] Β· Granted Feb 7, 2002 Β· Expires Feb 2, 2022

    expired
  24. WO 0210259

    POLYSILOXANPOLYMERE, VERFAHREN ZU IHRER HERSTELLUNG UND IHRE VERWENDUNG

    GE BAYER SILICONES GMBH & CO [DE] Β· Granted Feb 7, 2002 Β· Expires Feb 2, 2022

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.